Physicians' Academy for Cardiovascular Education

Phase 1 Study of CAT-2054, a Novel Oral Modulator of Sterol Regulatory Element Binding Protein

Slides (presentation) - June 18, 2015

Presentation prepared and held by Dr Joanne Donovan (Cambridge MA, USA) in Clinical Breakthroughs: A plethora of new therapeutic targets, May 2015, ISA2015 (Amsterdam, The Netherlands).

Phase 1 Study of CAT-2054, a Novel.pdf (0,8MB)Phase 1 Study of CAT-2054.pdf (0,8MB)

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: